_{25. Beard JL; Borel MJ, et al.: Impaired thermoregulation and thyroid function in irondeficiency anemia. Am J Clin Nutr 52:813–819, 1990.}

_{26. Bendall JR: Muscles, Molecules and Movement. American Elsevier Publishing Company, New York, 1969 (p. 162).}

_{27. Bennett RM, Clark SR, et al.: IGF-1 assays and other GH tests in 500 fibromyalgia patients (Abstract). J Musculoske Pain J.109, 1995.}

_{28. Beiger L, Gerson CD, Yu T: The effect of ascorbic acid on uric acid excretion with a commentary of the renal handling of ascorbic acid. Am J Med 62:71–76, 1977.}

_{29. Bemat I: Iron metabolism. Plenum Press, New York, 1983.}

_{30. Bezzano G: Effects of folic acid metabolism on serum cholesterol levels. Arch Intern Med 124:710–713, 1969.}

_{31. Bishnoi A, Carlson HE, et al.: Effects of commonly prescribed nonsteroidal antiinflammatory drugs on thyroid hormone measurements. Am J Med 96:235–238, 1994.}

_{32. Blum A: Do cigarette smokers need vitamin С supplementation? JAMA 244:193, 1980.}

_{33. Bochetta A, Bemardi F, et al.: Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand #3.193–198, 1991.}

_{34. Boni L, Kieckens L, Hendrikx A: An evaluation of a modified erythrocyte transketolase assay Гог assessing thiamine nutritional adequacy. J Nutri Sci Vitaminol 26:507–514, 1980.}

_{35. Botez MI, Cadotte M, Beaulieu R, et a!.: Neurologic disorders responsive to folic acid therapy. Can Med Assoc J 115:217–222, 1976.}

_{36. Botez MI, Peyronnard JM, Bachevalier J, et al.: Polyneuropathy and folate deficiency. Arch Neurol 35:581–585, 1978.}

_{37. Botez MI, Peyronnard JM, Charron L: Polyneuropathies responsive to folic acid therapy. Chapter 36. In: Folic Acid in Neurology, Psychiatry, and Internal Medicine. Edited by Botez Ml, Reynolds EH. Raven Press, New York, 1979 (p. 411).}

_{38. Bothwell TH: Overview and mechanisms of iron regulation. Nutrition Rev 53:237–245, 1995.}

_{39. Bourdillon JF: Spinal Manipulation. Ed. 2. Appleton-Centuiy-Crofts, New York, 1973 (pp. 39–43, Figs. 5-10).}

_{40. Ibid. (pp. 82–86).}

_{41. Brent GA: The molecular basis of thyroid hormone action. N Engl J Med 331:847–853, 1994.}

_{42. Brooke MH: A Clinicians View of Neuromuscular Disease. Williams & Wilkins, Baltimore, 1977.}

_{43. Bueding E, Stein MH, Wortis H: Blood pyruvate curves following glucose ingestion in normal and thiamine-deficient subjects. J Biol Chem 140:697–703, 1941.}

_{44. Calder JH, Curtis RC, Fore H: Comparison of vitamin С in plasma and leucocytes of smokers and non-smokers. Lancet 1:556, 1963.}

_{45. Cameron E: Biological function of ascorbic acid and the pathogenesis of scurvy. Med Hypotheses 2:154–163, 1976.}

_{46. Cameron E, Pauling L: Cancer and vitamin C. Linus Pauling Institute of Science and Medicine, Menio Park, Calif. 1979.}

_{47. Cameron N: Personality Development and Psychopathology: A Dynamic Approach. Houghton Mifflin, Boston, 1963.}

_{48. Canham JE, Baker EM, Harding RS, et al.: Dietary Protein — its relationship to vitamin B6 requirements and function. Ann NY Acad Sci 166:16–29, 1969 (pp. 16–29).}

_{49. Carmel R, Johnson CS: Racial patterns in pernicious anemia. N Engl J Med 298:647–650, 1978.}

_{50. Carmel R, Sinow RM, et al.: Atypical cobalamin deficiency. Subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with proteinbound cobalamin malabsorption. J Clin Med 109:454–463, 1987.}

_{51. Carmel R; Weiner JM et al.: Iron deficiency occurs frequently in patients with pernicious anemia. JAMA 257.1081–1083, 1987.}

_{52. Carney MW: Psychiatric aspects of folate deficiency. Chapter 42. In: Folic Acid in Neurology, Psychiatry, and Internal Medicine. Edited by Botez MI, Reynolds EH. Raven Press, New York, 1979 (pp. 480–482).}

_{53. Carney MW, Williams DG, Sheffield BF: Thiamine and pyridoxine lack in newlyadmitted psychiatric patients. Br J Psychiatry 135:249–254, 1979.}

_{54. Cass LJ, Frederik WS, Cohen JD: Chronic disease and vitamin C. Geriatrics 9:375–380, 1954.}

_{55. Chanarin I: The megaloblastic anemias. Ed. 2. Blackwell: Oxford, 1979.}

_{56. Charlton RW; Bothwell TH: Iron absorption. Ann Rev Med 34:55–68, 1983.}

_{57. Chaudhuri CR, Chatterjee IB: L-Ascorbic acid synthesis in birds: phylogenetic trend. Science 164:435–436, 1969.}

_{58. Cheraskin E, Ringsdorf WM Jr: A relationship between vitamin С intake and electrocardiography. J Electrocardiol 12:441, 1979.}

_{59. Chu J: Dry needling (intramuscular stimulation) in myofascial pain related to lumbosacral radiculopathy. Eur J Phys Med Rehabil 5(4): 106–121, 1995.}

_{60. Chu J: Twitch-obtaining intramuscular stimulation: its effectiveness in the longterm treatment of myofascial pain related to lumbosacral radiculopathy [Abstract). Arch Phys Med Rehabil 78:1024, 1997.}

_{61. Ciaccio El: The vitamins. Chapter 62. In: Drill’s Pharmacology in Medicine. Ed. 4. Edited by DiPalma JR. New York, McGraw-Hill, 1971 (pp. 1293–1294). a}

_{62. Ibid. (pp. 1282–1284, 1287–1290). b}

_{63. Crook WG; Can what a child eats make him dull, stupid, or hyperactive? J Learn Disabil 13:281–286, 1980.}

_{64. Danese MD, Powe NR, et al.: Screening for mild thyroid failure at the periodic health exam. JAMA 276:285–292, 1996.}

_{65. Davalos A, Fernandez-Real JM, et al.: Iron-related damage in acute ischemic stroke. Stroke 25.1543–1546, 1994.}

_{66. Dayan CM, Daniels GH: Chronic autoimmune thyroiditis. N Engl J Med 335:99—107, 1996.}

_{67. DeMaeyer E, Adiels-Tegman M: The prevalence of anemia in the world. World Health Statist Q 38:302–316, 1985.}

_{68. Dempsey WB: Vitamin B6 and pregnancy. Chapter 12. In: Human Vitamin Bt Requirements: National Academy of Sciences, Washington, 1978 (pp. 202, 203).}

_{69. Dickerson JW: Vitamin requirements in different clinical conditions. Biblthca Nutr Dicta 35:44–52, 1985.}

_{70. Diffrient N, Tilley AR, Bardagiy JC: Humanscale 1/2/3. Massachusettes Institute of Technology Press, Cambridge, 1974 (pp. 19–22).}

_{71. Diliman E, Johnson DG, et al.: Catecholamine elevation in iron deficiency. Am J Physiol 237:R297—R300, 1979.}

_{72. Dipalma JR: Vitamin toxicity. Am Fam Phys 18:106–109, 1978.}

_{73. Donaldson RM Jr.: Serum Bu and the diagnosis of cobalamin deficiency. N Engl J Med 299:827–828, 1978.}

_{74. Dong BJ, Hauck WW, et al.: Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA 277:1205–1213, 1997.}

_{75. Dreosti IE: Magnesium status and health. Nutrition Reviews 53:S23—S27, 1995.}

_{76. Driskell JA: Vitamin В6 status of the elderly. Chapter 16. In: Human Vitamin Bt Requirements. National Academy of Sciences. Washington, 1978 (pp. 252–255).}

_{77. Driskell JA, Chnsley BM, et al.: Plasma pyridoxal phosphate concentrations of men fed different levels of vitamin B-6. Am J Clin Nutr 48:42–46, 1988.}

_{78. Dumitru D: Electrodiagnostic Medicine. Hanley & Balfus, Philadelphia, 1997 (pp. 1083–1084).}

_{79. Ebadi M. Vitamin B6 and biogenic amines in brain metabolism. Chapter 8. In: Human Vitamin B6 Requirements, National Academy of Sciences. Washington, 1978 (pp. 129–150).}

_{80. Ellis JM, Kishi T, Azuma J, et al: Vitamin B6 deficiency in patients with a clinical syndrome including the carpal tunnel effect Biochemical and clinical response to therapy with pyridoxine. Res Commun Chem Pathol Pharmacol 3:743–757, 1976.}